Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib cardiac repolarization study in advanced cancer
NCT01328054Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind, single-arm trial of lapatinib in solid tumor and breast cancer, sponsored by GSK. Primary endpoint: Fridericia-corrected QT Interval at Day 4. Started Dec 2011; status: completed.
02
Drugs
lapatinib
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT01328054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328054.